Skip to main content

MYC requirement

oncogene is required to maintain tumorigenesis.

Written byJonathan Weitzman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

There is increasing evidence that sustained oncogene expression may be required to maintain the cancer state, implying that therapeutic strategies that use transient pharmacological inactivation may prove effective. In the 5 July Science, Meenakshi Jain and colleagues describe an elegant experimental model to explore the effect of brief oncogene inactivation (Science 2002, 297:102-104).

Jain et al. studied a transgenic mouse strain in which the conditional expression of the MYC oncogene can be regulated by tetracycline. Some of these mice develop osteogenic sarcomas. Inactivation of the MYC transgene caused regression and differentiation of the tumor cells. Upon reactivation of MYC expression the cells did not revert to neoplastic tumors but underwent apoptosis. The authors propose that brief inactivation of oncogene expression changes the epigenetic context, revoking the ability to maintain tumorigenesis.

These are promising results for future cancer therapies directed against oncogenes, suggesting that it might be possible to mitigate toxicities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Illustrated floating metabolites and molecules

Metabolon Verus™ Kit: Metabolomics Profiling Kit

Metabolon
Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics